Ivan Nikolić

<i>Lactobacillus helveticus</i> Lafti L10 supplementation reduces respiratory infection duration in a cohort of elite athletes: a randomized, double-blind, placebo-controlled trial

Danica Michaličková, Rajna Minić, Nenad Dikić et al. · Applied Physiology Nutrition and Metabolism · 2016 · 69 citations · Full text

COVID-19 vaccines and cancer patients: acceptance, attitudes and safety.

Gorana Matovina Brko, Maja Popović, Masa Jovic et al. · PubMed · 2021 · 24 citations

Phase II Trial of HER-Vaxx, a B-cell Peptide-Based Vaccine, in HER2-Overexpressing Advanced Gastric Cancer Patients Under Platinum-Based Chemotherapy (HERIZON)

Joshua Tobias, Marina Maglakelidze, Zoran Andrić et al. · Clinical Cancer Research · 2024 · 19 citations · Full text

Locally advanced rectal cancers with simultaneous occurrence of KRAS mutation and high VEGF expression show invasive characteristics

Milena Krajnović, Bojana Marković, Slavica Knežević‐Ušaj et al. · Pathology - Research and Practice · 2016 · 16 citations

Medicine, Kras Mutation, Colorectal Cancer +9

HERIZON: A phase 2 study of HER-Vaxx (IMU-131), a HER2-targeting peptide vaccine, plus standard of care chemotherapy in patients with HER2-overexpressing metastatic or advanced gastric/GEJ adenocarcinoma— Overall survival analysis.

Marina Maglakelidze, Dinara Ryspayeva, Zoran Andrić et al. · Journal of Clinical Oncology · 2023 · 12 citations

Cancer Management, Immunology, Immunotherapeutics +19